Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) FCF Margin (2017 - 2020)

Historic FCF Margin for Cogent Biosciences (COGT) over the last 4 years, with Q3 2020 value amounting to 3290.71%.

  • Cogent Biosciences' FCF Margin fell 22921800.0% to 3290.71% in Q3 2020 from the same period last year, while for Jun 2021 it was 13945.51%, marking a year-over-year decrease of 137994500.0%. This contributed to the annual value of 8687.07% for FY2025, which is N/A changed from last year.
  • Latest data reveals that Cogent Biosciences reported FCF Margin of 3290.71% as of Q3 2020, which was down 22921800.0% from 1576.52% recorded in Q2 2020.
  • In the past 5 years, Cogent Biosciences' FCF Margin registered a high of 55.32% during Q4 2019, and its lowest value of 3290.71% during Q3 2020.
  • Moreover, its 4-year median value for FCF Margin was 364.37% (2018), whereas its average is 636.15%.
  • Over the last 5 years, Cogent Biosciences' FCF Margin had its largest YoY gain of 2663800bps in 2020, and its largest YoY loss of -22921800bps in 2020.
  • Quarter analysis of 4 years shows Cogent Biosciences' FCF Margin stood at 311.63% in 2017, then rose by 24bps to 237.06% in 2018, then surged by 77bps to 55.32% in 2019, then crashed by -5848bps to 3290.71% in 2020.
  • Its last three reported values are 3290.71% in Q3 2020, 1576.52% for Q2 2020, and 112.26% during Q1 2020.